3-Phosphoinositide-Dependent Kinase 1 As a Therapeutic Target for Treating Diabetes

Overview

Journal Curr Diabetes Rev

Publisher Bentham Science Publishers

Specialty Endocrinology

Date 2024 Mar 12

PMID 38468518

Authors

Xie Xiang

Pan Shuya

Zhang Jiamin

Zhang Zihan

Yang Xumei

Liu Jingjin

Affiliations

Soon will be listed here.

Abstract

The role of 3-phosphoinositide-dependent kinase 1 (PDK1) has been welldocumented in the development of diabetes. This review offers a thorough examination of its composition and associated routes, specifically focusing on insulin signaling and glucose processing. By examining the precise connection between PDK1 and diabetes, various strategies specifically targeting PDK1 were also investigated. Additionally, recent discoveries from mouse models were compiled where PDK1 was knocked out in certain tissues, which demonstrated encouraging outcomes for focused treatments despite the absence of any currently approved clinical PDK1 activators. Moreover, the dual nature of PDK1 activation was discussed, encompassing both anti-diabetic and pro-oncogenic effects. Hence, the development of a PDK1 modifier is of utmost importance, as it can activate anti-diabetic pathways while inhibiting pro-oncogenic pathways, thus aiding in the treatment of diabetes. In general, PDK1 presents a noteworthy opportunity for future therapeutic strategies in the treatment of diabetes.

References

Mahgoub M, Ali I, Adeghate J, Tekes K, Kalasz H, Adeghate E . An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus. Int J Mol Sci. 2023; 24(11). PMC: 10253663. DOI: 10.3390/ijms24119328. View

Nakae J, Biggs 3rd W, Kitamura T, Cavenee W, Wright C, Arden K . Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet. 2002; 32(2):245-53. DOI: 10.1038/ng890. View

Jiang Q, Zhang X, Dai X, Han S, Wu X, Wang L . S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions. Nat Commun. 2022; 13(1):1548. PMC: 8941131. DOI: 10.1038/s41467-022-28910-8. View

Bayascas J . PDK1: the major transducer of PI 3-kinase actions. Curr Top Microbiol Immunol. 2010; 346:9-29. DOI: 10.1007/82_2010_43. View

Dong L, Zhang R, Langlais P, He H, Clark M, Zhu L . Primary structure, tissue distribution, and expression of mouse phosphoinositide-dependent protein kinase-1, a protein kinase that phosphorylates and activates protein kinase Czeta. J Biol Chem. 1999; 274(12):8117-22. DOI: 10.1074/jbc.274.12.8117. View

Tawaramoto K, Kotani K, Hashiramoto M, Kanda Y, Nagare T, Sakaue H . Ablation of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in vascular endothelial cells enhances insulin sensitivity by reducing visceral fat and suppressing angiogenesis. Mol Endocrinol. 2011; 26(1):95-109. PMC: 5417157. DOI: 10.1210/me.2010-0412. View

Song B, Alam M, Lee S . Terpenoid-Rich Extract of L. Bark Displays Antidiabetic Action in Insulin-Resistant C2C12 Cells and STZ-Induced Diabetic Mice by Attenuation of Oxidative Stress. Antioxidants (Basel). 2022; 11(7). PMC: 9312268. DOI: 10.3390/antiox11071227. View

Maiese K, Morhan S, Chong Z . Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res. 2007; 4(1):63-71. PMC: 2387116. DOI: 10.2174/156720207779940653. View

Katase N, Nishimatsu S, Yamauchi A, Yamamura M, Fujita S . DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways. Int J Oncol. 2018; 54(3):1021-1032. DOI: 10.3892/ijo.2018.4667. View

10.

Sato S, Fujita N, Tsuruo T . Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway. J Biol Chem. 2004; 279(32):33759-67. DOI: 10.1074/jbc.M402055200. View

11.

Liu C, Pei J, Mu X, Yu B, Gong T, Liang W . [Ponatinib inhibits the proliferation of SNU-449 human hepatocellular cancer cells and blocks MAPK and PDK1/AKT/mTOR signaling pathways]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022; 38(5):425-431. View

12.

Hosooka T, Hosokawa Y, Matsugi K, Shinohara M, Senga Y, Tamori Y . The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B axis. Proc Natl Acad Sci U S A. 2020; 117(21):11674-11684. PMC: 7261087. DOI: 10.1073/pnas.1921015117. View

13.

Alessi D, James S, Downes C, Holmes A, Gaffney P, Reese C . Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol. 1997; 7(4):261-9. DOI: 10.1016/s0960-9822(06)00122-9. View

14.

Alessi D, Deak M, Casamayor A, Caudwell F, Morrice N, Norman D . 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol. 1997; 7(10):776-89. DOI: 10.1016/s0960-9822(06)00336-8. View

15.

Pearce L, Komander D, Alessi D . The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2009; 11(1):9-22. DOI: 10.1038/nrm2822. View

16.

Biondi R, Komander D, Thomas C, Lizcano J, Deak M, Alessi D . High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site. EMBO J. 2002; 21(16):4219-28. PMC: 126174. DOI: 10.1093/emboj/cdf437. View

17.

Komander D, Kular G, Deak M, Alessi D, van Aalten D . Role of T-loop phosphorylation in PDK1 activation, stability, and substrate binding. J Biol Chem. 2005; 280(19):18797-802. DOI: 10.1074/jbc.M500977200. View

18.

Collins B, Deak M, Murray-Tait V, Storey K, Alessi D . In vivo role of the phosphate groove of PDK1 defined by knockin mutation. J Cell Sci. 2005; 118(Pt 21):5023-34. DOI: 10.1242/jcs.02617. View

19.

Xu X, Chen Y, Fu Q, Ni D, Zhang J, Li X . The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1. J Enzyme Inhib Med Chem. 2019; 34(1):361-374. PMC: 6327997. DOI: 10.1080/14756366.2018.1553167. View

20.

Boucher J, Kleinridders A, Kahn C . Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014; 6(1). PMC: 3941218. DOI: 10.1101/cshperspect.a009191. View